Efficacy is obviously important, Poh says, but so is finding the right balance of toxicity, convenience and value for ...
Fevers, drenching night sweats, weight loss, significant or progressive lymphadenopathy, involvement of the bone marrow that ...
In theory, agentic AI’s ability to self-refine could mean improved patient outcomes. Hennessy says it also raises questions for regulators and end users, because assessments of AI agents will quickly ...
From increasing price transparency to curbing prescription drug costs, states are trying to figure out how to rein in rising ...
University of Utah Health researchers have shown that a protein involved in cancer growth also plays a role in whether a ...
A single 10 mg dose of oral hydrocortisone improved attention and verbal learning within hours in virally suppressed women with HIV, and daily dosing over four weeks was linked to gains in delayed ...
The FDA has approved Mimrylo (rusfertide) to treat adults with polycythemia vera (PV), a blood cancer that causes the overproduction of red blood cells. The excess cells thicken t ...
Repatha (evolocumab) lowered the risk of death from any cause by 20% in high-risk adults without a previous heart attack or ...
Margaret A. Murray, M.P.A., CEO of the Association for Community Affiliated Plans, says outreach and texting will be key to keeping eligible Medicaid enrollees covered under new redetermination and ...
The FDA has approved Lilly’s Mounjaro (tirzepatide) to lower the risk of major adverse cardiovascular events (MACE), including cardiovascular death, non-fatal heart attack, or non-fatal stroke in ...
University of Maryland researchers used machine learning models trained on claims data of adults with diabetes to predict ...
The FDA has approved Lisraya (brepocitinib) to treat adults with dermatomyositis, rare autoimmune disease. Dermatomyositis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results